GDI will provide the necessary umbrella structure to facilitate integration, partnership building, and coordination of activities. As an initiative with broad-based multi-institutional and multi-sectoral membership (with core secretariat functions provided by WHO), it is expected to be in a position to influence and facilitate the much needed integration and sustainability of DR-TB care as part of overall health systems strengthening, both at global and country level.

Organizationally, the GDI shall continue to be one of the Working Groups of the Stop TB Partnership. Structurally, the CG consists of individuals with expertise in multiple disciplines representing constituencies, stakeholders, and institutions participating in the Stop TB Partnership, and involved in global and country-level improvement and scale-up of programmatic management of DR-TB.

The GDI Secretariat will continue to be provided by the Laboratories, Diagnostics and Drug Resistance (LDR) Unit of the WHO Global TB Programme and hosted in the WHO Headquarters in Geneva.

The CG will convene activity- or project specific, time-limited task forces to undertake specific tasks. The members of such technical groups will be selected from within the overall Working Group partners and assigning a lead partner. The CG will undertake at least one mid-term review and one-end-of- term review of activities undertaken by these technical groups. Products/deliverables of these groups will be presented to the GDI Working Group during annual meetings.